E. Wardelmann

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Litière, A. Cesne, H. Joensuu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma

O. Larsson, P. Schirmacher, R. Penzel, 2014, Oncogene.

KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape

J. Sicklick, M. von Mehren, Isabella Klooster, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.

E. Wardelmann, T. Sauerbruch, A. Glasmacher, 2005, Anticancer research.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.